Asia Pacific Aquaculture Vaccines Market

The Asia Pacific aquaculture vaccines market is expected to grow from US$ 33.05 million in 2022 to US$ 74.98 million by 2028. It is estimated to grow at a CAGR of 14.6% from 2022 to 2028. 

Rising Prevalence of Infectious Diseases in Aquatic Animals is Driving the Asia Pacific Aquaculture Vaccines Market

As per the research study titled "Prevalence of Anisakid Nematodes in Fish in China: A Systematic Review and Meta-Analysis" published by the National Library of Medicine (NLM) in February 2022, the anisakid nematodes were widespread in fish across China with a pooled incidence rate of 45.5% and the occurrence percentage for fresh fish was the greatest (58.1%). Eastern China had the highest prevalence rate of anisakid nematodes (55.3%), while the prevalence of anisakid nematodes (76.8%) was highest in East China Sea. According to the data published in Aquaculture Research & Development journal, ~219 cases of infectious diseases in the fresh aquaculture sector were registered from 2014 to 2018. Among these, 74.88% were parasitic, 12.80% were bacterial, 1.83% were viral, and 10.50% cases were a mix of parasitic and bacterial diseases. Therefore, the high prevalence of infectious diseases is expected to boost the demand for vaccines, which would provide lucrative opportunities for the aquaculture vaccines market in the coming years.  

Asia Pacific Aquaculture Vaccines Market Overview

The Asia Pacific aquaculture vaccines market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The market growth in these countries is attributed to the rising aquaculture sector in the region and favorable government initiatives. Moreover, expansion and product launch strategies implemented by market players are expected to contribute to the growth of the aquaculture vaccines market in the region. As a major consumer market, China drives significant demand for seafood. Species such as trout and salmon, which were once considered as luxurious are now affordable to the country’s middle-class consumers. Additionally, by 2030, China will become an overconsumer of seafood and will require between 6 to 18 tons of seafood to meet consumer demand, according to a 2020 report from the Stockholm Resilience Centre. This is due to rapidly growing levels of seafood consumption, with Chinese consumers consuming over 35 kg of seafood per person in 2020. According to the Chinese Academy of Engineering Forecast, total aquaculture demand and production will grow from 81 million tonnes to 100 million tonnes by 2035. Thus, China's strategy to move towards a market-based, demand-driven economy for aquaculture products, growing fish diseases, and rising demand for seafood among the population will support the aquaculture vaccines market growth. 

 Asia Pacific Aquaculture Vaccines Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Aquaculture Vaccines Strategic Insights

Strategic insights for the Asia Pacific Aquaculture Vaccines provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Asia Pacific Aquaculture Vaccines Report Scope

Asia Pacific Aquaculture Vaccines Regional Insights

The geographic scope of the Asia Pacific Aquaculture Vaccines refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

Asia Pacific Aquaculture Vaccines Market Segmentation 

The Asia Pacific aquaculture vaccines market is segmented into type of vaccine, species, route of administration, and country.

Based on type of vaccine the Asia Pacific aquaculture vaccines market, is segmented into live vaccines, inactivated vaccines, other vaccines. The inactivated vaccines segment held the largest market share in in 2022.

Based on species, the Asia Pacific aquaculture vaccines market is divided into tilapia, trout, salmon, shrimps, and others. The salmon segment held the largest share of the market in 2022

Based on route of administration the Asia Pacific aquaculture vaccines market, is segmented into injection vaccines, immersions vaccines, and oral vaccines. The injection vaccines segment held the largest share of the market in 2022.

Based on country, the Asia Pacific aquaculture vaccines market is segmented into the Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. China dominated the aquaculture vaccines market share in 2022. 

Elanco Animal Health Inc; HIPRA SA; Merck & Co Inc.; Phibro Animal Health Corp; Zoetis Inc.; Indian Immunologicals Ltd; and Nisseiken Co Ltd are the leading companies operating in the Asia Pacific aquaculture vaccines market.